- Home
- COLB vs KRYS Comparison
COLB vs KRYS Comparison
Compare COLB & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COLB | KRYS |
|---|---|---|
| Founded | 1993 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 9.6B |
| IPO Year | 1996 | 2017 |
Fundamental Metrics
Financial Performance| Metric | COLB | KRYS |
|---|---|---|
| Price | $29.95 | $349.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 11 |
| Target Price | $31.46 | ★ $297.60 |
| AVG Volume (30 Days) | ★ 2.8M | 200.3K |
| Earning Date | 04-23-2026 | 05-04-2026 |
| Dividend Yield | ★ 5.08% | N/A |
| EPS Growth | N/A | ★ 128.00 |
| EPS | 1.38 | ★ 3.62 |
| Revenue | $177,000,000.00 | ★ $389,130,000.00 |
| Revenue This Year | $31.52 | $38.74 |
| Revenue Next Year | $2.90 | $32.53 |
| P/E Ratio | ★ $21.62 | $96.16 |
| Revenue Growth | 18.94 | ★ 33.94 |
| 52 Week Low | $23.83 | $145.46 |
| 52 Week High | $33.68 | $382.54 |
Technical Indicators
Market Signals| Indicator | COLB | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 41.12 | 48.23 |
| Support Level | $29.77 | $289.36 |
| Resistance Level | $30.00 | $382.33 |
| Average True Range (ATR) | 0.61 | 11.24 |
| MACD | -0.04 | -0.73 |
| Stochastic Oscillator | 34.58 | 28.36 |
Price Performance
Historical ComparisonAbout COLB Columbia Banking System Inc.
Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.